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ABSTRACT 
    Abdominal aortic aneurysm (AAA) is known to develop mainly by the increased 
diameter of aorta through metalloproteinases (MMPs). Although activities of MMPs are 
tightly regulated by the presence of tissue inhibitor of MMPs (TIMPs) and imbalances 
between MMPs and TIMPs may serve to fragility of arterial wall, little is known about 
TIMPs behavior in aneurysmal formation. Here, we utilized a murine experimental 
AAA model, and found that by immunohistochemical analysis, Timp1 as well as Mmp9 
was accumulated in the medial layer of aorta. Up-regulation of Mmp9 and Timp1 
mRNA levels was also revealed in aortic tissue in AAA by RT-PCR. In cultured vascular 
smooth muscle cells (SMCs), Tumor Necrosis Factor (TNF)-α significantly activated 
both Mmp9 and Timp1 expression, and they were blocked by Jun kinase inhibitor 
(SP600125) in a dose-dependent manner. Interestingly, a proteasome inhibitor (MG132), 
which is known as an agent for inhibition of the nuclear factor-kappa B (NF-kB), 
significantly inhibited the TNF-α-induced expression of Timp1, whereas MG132, which 
also works as an activator of c-Jun/AP-1 pathway, strongly increased Mmp9. Taken 
together, inflammatory cytokines, including TNF-α, may simultaneously induce MMPs 
and TIMPs for remodeling of the medial layer, leading to increased diameter of aorta, 
the aneurysm. 
 
